+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin



Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin



Journal of Antimicrobial ChemoTherapy 25(4): 567-574



The in-vitro synergistic activity of tazobactam, a new beta-lactamase inhibitor, combined with piperacillin was tested against various beta-lactamase-producing strains. The beta-lactamase inhibitory activity of tazobactam against various known types of beta-lactamase was also tested in comparison with clavulanic acid or sulbactam. Tazobactam caused a remarkable reduction of the piperacillin MICs for penicillinase- and oxyiminocephalosporinase-producing strains and also showed a moderate synergistic effect against cephalosporinase-producing strains. The bactericidal activity of piperacillin was enhanced in combination with tazobactam. Tazobactam inhibited the penicillinases, and the oxyiminocephalosporinase produced by Proteus vulgaris, at low concentration. In these cases its activity was comparable with that of clavulanic acid and stronger than that of sulbactam. Tazobactam demonstrated a better inhibitory capability than sulbactam against the cephalosporinases tested. Tazobactam was able to inactivate intracellular beta-lactamase in Prot. vulgaris and Morganella morganii, confirming its ability to penetrate the cell membrane of these species.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040444245

Download citation: RISBibTeXText

PMID: 2161820


Related references

Inhibition of -lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin. Journal of Antimicrobial Chemotherapy 25(4): 567-574, 1990

In vitro antibacterial activity of cefoperazone combined with tazobactam against clinical isolates producing beta-lactamases. Zhongguo Kangshengsu Zazhi 26(5): 365-367, 2001

In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE 2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin). Infection 19(5 Suppl.): S264-S275, 1991

In vitro activity and stability against novel beta lactamases of investigational beta lactams cefepime cefpirome flomoxef sce 2787 and piperacillin plus tazobactam in comparison with established compounds cefotaxime latamoxef and piperacillin. Infection 19(Suppl. 5): S264-S275, 1991

A national multicenter study of the in-vitro activity of piperacillin-tazobactam. The Spanish Piperacillin-Tazobactam Group. Revista Espanola de Quimioterapia 11(2): 139-146, 1998

In vitro activity of piperacillin-tazobactam against Klebsiella pneumoniae clinical isolates, producers or not of extended spectrum beta-lactamases. Revista Espanola de Quimioterapia 12(3): 229-233, 1999

Efficiency of tazobactam as inhibitor of beta-lactamases, combined with piperacillin, against resistant strains to this penicillin. Medicina Clinica 92(10): 371-374, 1989

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830). Diagnostic Microbiology and Infectious Disease 12(6): 481-488, 1989

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli. Antimicrobial Agents and ChemoTherapy 60(12): 7527-7529, 2016

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Klebsiella pneumoniae Strains. Antimicrobial Agents and ChemoTherapy 61(7):, 2017

In vitro synergistic activity of piperacillin combined with tazobactam against beta lactam resistant strains of enterobacteriaceae. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 31: 117, 1991

Activity of piperacillin and ticarcillin combined with tazobactam or clavulanic acid against beta lactamase producing piperacillin resistant isolates. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 32: 131, 1992

Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates. Journal of ChemoTherapy 2(5): 295-299, 1990

Antibacterial activity of piperacillin and tazobactam against beta-lactamase-producing clinical isolates. ChemoTherapy 36(5): 356-364, 1990

The study of stability on piperacillin/tazobactam to beta-lactamases. Zhongguo Kangshengsu Zazhi 25(1): 28-32, 46, 2000